You have 9 free searches left this month | for more free features.

Immunocytokine

Showing 1 - 25 of 34

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cancer Of Prostate Trial run by the National Cancer Institute (NCI) (M9241, Stereotactic Body Radiation Therapy (SBRT))

Recruiting
  • Cancer Of Prostate
  • M9241
  • Stereotactic Body Radiation Therapy (SBRT)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Histologically or Cytologically Confirmed Pancreatic Cancer, Unresectable or Borderline Resectable Pancreatic Cancer, Pancreatic

Terminated
  • Histologically or Cytologically Confirmed Pancreatic Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 19, 2022

Breast Carcinoma, Colorectal Carcinoma Trial in Duarte (procedure, drug, radiation)

Not yet recruiting
  • Breast Carcinoma
  • Colorectal Carcinoma
  • Biopsy
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Nov 8, 2023

Melanoma Trial in Madison (hu14.18-IL2, Radiation Therapy, Nivolumab)

Suspended
  • Melanoma
  • hu14.18-IL2
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Jan 3, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Adenocarcinoma, Metastatic Breast Carcinoma Trial in

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 2, 2022

B-cell Non-Hodgkin Lymphoma Trial in Duarte, Minneapolis, Lebanon (DI-Leu16-IL2)

Terminated
  • B-cell Non-Hodgkin Lymphoma
  • Duarte, California
  • +2 more
Nov 2, 2020

Solid Tumors Trial in Worldwide (RO7284755, Atezolizumab)

Recruiting
  • Solid Tumors
  • Bruxelles, Belgium
  • +12 more
Jan 23, 2023

Solid Tumor, Breast Cancer, Cancer of Head and Neck Trial in Worldwide (RO6874281, Trastuzumab, Cetuximab)

Completed
  • Solid Tumor
  • +2 more
  • Tucson, Arizona
  • +25 more
Nov 21, 2022

B-cell Non-Hodgkin Lymphoma Trial in United States (DI-Leu16-IL2)

Terminated
  • B-cell Non-Hodgkin Lymphoma
  • Duarte, California
  • +4 more
Nov 2, 2020

Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers Trial in Worldwide (simlukafusp alfa, Atezolizumab

Completed
  • Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers
  • simlukafusp alfa
  • +3 more
  • San Francisco, California
  • +43 more
Feb 18, 2022

Cervical Cancer, HPV Cancers, Anal Cancer Trial run by the NCI (PDS0101, M7824, NHS-IL12)

Active, not recruiting
  • Cervical Cancer
  • +4 more
  • PDS0101
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Kaposi Sarcoma Trial run by the NCI (NHS-IL12, M7824)

Recruiting
  • Kaposi Sarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Cancer Of Prostate, Prostate Tumors Trial run by the National Cancer Institute (NCI) (ADT, Prednisone, M7824)

Recruiting
  • Cancer Of Prostate
  • Prostate Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Urothelial Cancer, Bladder Cancer, Genitourinary Cancer Trial run by the NCI (M7824, M9241, Stereotactic body radiation therapy

Recruiting
  • Urothelial Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Cancer, Solid Tumor, Metastatic Checkpoint Refractory HPV Associated Malignancies Trial run by the National Cancer Institute

Recruiting
  • Cancer
  • +3 more
  • Bintrafusp Alfa
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 11, 2022

Prostate Cancer, Recurrent Prostate Cancer, PET Positive Trial run by the National Cancer Institute (NCI) (Enzalutamide, M9241)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 27, 2023

Solid Tumors Trial in Worldwide (Atezolizumab, Cergutuzumab Amunaleukin)

Completed
  • Solid Tumors
  • New Haven, Connecticut
  • +13 more
Jan 15, 2020

Advanced Solid Tumor, Metastatic Solid Tumor Trial in Seoul (GI-102)

Recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • Seoul, Korea, Republic of
  • +3 more
Apr 20, 2023

Small Bowel Cancers, Colorectal Cancers Trial run by the NCI (CV301, MSB0011359C, N-803)

Recruiting
  • Small Bowel Cancers
  • Colorectal Cancers
  • CV301
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Colorectal Cancer Trial run by the National Cancer

Recruiting
  • Metastatic Colorectal Cancer (Mcrc)
  • +7 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Epithelial Tumors, Malignant, Epithelial Tumors, Malignant, Malignant Mesenchymal Tumor Trial run by the NCI (NHS-IL-12)

Completed
  • Epithelial Neoplasms, Malignant
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 15, 2021

Neuroblastoma Trial in Madison, Southampton, London (Nivolumab, Ch14.18/CHO)

Recruiting
  • Neuroblastoma
  • Madison, Wisconsin
  • +2 more
Mar 28, 2022

specific Patient Decision Aid (tPDA) of the ImmunoSABR Phase 2

Not yet recruiting
  • NSCLC Stage IV
  • +3 more
  • Decision tool
  • (no location specified)
Oct 21, 2020

NSCLC Stage IV, Metastatic Disease Trial in Worldwide (Darleukin, Radiation)

Recruiting
  • NSCLC Stage IV
  • Metastatic Disease
  • Brussel, Belgium
  • +14 more
Oct 19, 2020

Urothelial Cancer Trial run by the NCI (Bintrafusp alfa (M7824))

Terminated
  • Urothelial Cancer
  • Bintrafusp alfa (M7824)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 25, 2022